Policy paper

Future of NICE: government response to select committee recommendations

This publication was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Response to the Health Select Committee's recommendations on the future of the National Institute for Health and Clinical Excellence (NICE).

Document

Government Response to the Health Select Committee’s Eighth Report of Session 2012-13 on the National Institute for Health and Clinical Excellence

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

In this publication, the government confirms that the National Institute for Health and Clinical Excellence (NICE) will:

  • play an important part in the future value-based pricing of branded medicines
  • have a bigger role in evaluating drugs, through assessing a medicine’s benefits and costs

This will help make sure that the price the NHS pays for new medicines is more closely linked to their value to NHS patients and society.